Newronika
PrivateLast Round
Series B
Feb 13, 2025
Total Funding Raised
$27.85M
Company Overview
Newronika is a medtech company that develops adaptive deep brain stimulation technology to treat neurological disorders such as Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Newronika Comparables
Compare Newronika with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aleva Neurotherapeutics | 82% | |
| Medtronic | 82% | |
| 景昱医疗科技（苏州）股份有限公司 | 76% | |
Newronika Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 13, 2025 | ||||
| VC Round | Jan 22, 2024 | ||||
| Grant | Mar 8, 2023 | ||||
| Series A | Sep 26, 2019 | ||||
| Seed | Jun 14, 2016 |
Newronika Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TNBT Capital | Series B |
| European Innovation Council Fund | Grant |
| Innogest Capital | Series A, Series B |
| Indaco Venture Partners SGR | Series A, Series B |
| F3F | Series A, Series B |
| Origine SGR | Series B, Seed |
| Wille Finance AG | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 13, 2025
$14.1M round completed.
- Mar 8, 2023
$2.65M grant from European Innovation Council Fund
Newronika Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Newronika's valuation, stock price, and market status.